Hetero Labs Limited Dolutegravir Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Dolutegravir Export Records India — #2 Exporter, 709 Shipments, $35.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dolutegravir

India Pharmaceutical Trade Intelligence

$4.2B104 Suppliers145 CountriesHS 30049099

ExportsIndia → BOTSWANA75.3%India → TANZANIA6.1%

ImportsCANADA → India$1.0M UNITED STATES → India$970.9K

#1 Buyer: AFRICURE PHARMACEUTICALS

Hetero Labs Limited — Dolutegravir Exporter #2 | $35.5M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Dolutegravir Exporter Profile

Indian Pharmaceutical Exporter · #2 for Dolutegravir · $35.5M export value · DGFT Verified

Hetero Labs Limited is the #2 Indian exporter of Dolutegravir with $35.5M in export value and 709 verified shipments. Hetero Labs Limited holds a 0.8% market share in Dolutegravir exports across 94 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Dolutegravir Export Profile: Buyers & Destinations

Hetero Labs Limited Dolutegravir export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Dolutegravir?

Country	Value	Shipments	Share
NIGERIA	$3.3M	68	12.9%
SOUTH AFRICA	$3.0M	62	12.0%
KENYA	$2.5M	51	9.9%
PHILIPPINES	$1.8M	38	7.1%

Who Are the Top Buyers of Dolutegravir from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	UNITED ARAB EMIRATES	$12.6M	321
TO THE ORDER	ZAMBIA	$2.5M	63
HOANG DUC PHARMACEUTICAL &	VIETNAM	$803.7K	17
HOANG DUC PHARMACEUTICAL & MEDICAL	VIETNAM	$500.0K	10
TO THE ORDER OF,	KAZAKISTAN	$450.0K	9
M S TO THE ORDER OFTHE MISSION DIRECTOR USAGENCY	NIGERIA	$450.0K	9
M/S	KAZAKISTAN	$441.2K	14
SEVEN PHARMA S.A.C,	PERU	$350.0K	7
XXTERXXDRUXX SOXXH AXXICAXXPTYXXLIMITEDX	SOUTH AFRICA	$300.0K	6
SEVEN PHARMA S.A.C.,	PERU	$300.0K	6

Hetero Labs Limited supplies Dolutegravir to 115 buyers globally. The largest buyer is TO THE ORDER OF (UNITED ARAB EMIRATES), followed by TO THE ORDER (ZAMBIA) and HOANG DUC PHARMACEUTICAL & (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dolutegravir Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
DOLUTEGRAVIR 50 + LAMIVUDINE 300 + TENOF	$2.0M	59
DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLET	$964.5K	26
DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPR	$761.8K	17
TELDY DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIRDISOPR TABLET	$616.3K	13
LUVIGEN DOLUTEGRAVIR + LAMIVUDINE+TENOFOVIR DISOPR TABLETS GREEN CARD NO.518/VSEZ DT. 15.03.26NOS	$450.0K	9
DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DI	$418.9K	14
DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPRTABLETS	$378.4K	8
DOLUTEGRAVIR 50+LAMIVUDINE 300+TENOFOVIR	$370.1K	8
DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISO. FUM.(TELDY)	$350.0K	7
DOLUTEGRAVIR+LAMIVUDINE+TENOFOVIR DISOPR50MG+300MG+300MG TABLET 30S	$335.3K	16

Hetero Labs Limited exports 341 distinct Dolutegravir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOLUTEGRAVIR 50 + LAMIVUDINE 300 + TENOF with 59 shipments worth $2.0M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Hetero Labs Limited Compare to Nearest Dolutegravir Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	CIPLA LIMITED	$47.5M	949	40	$50.0K
2	HETERO LABS LIMITED ★	$35.5M	709	94	$50.0K
3	EMCURE PHARMACEUTICALS LIMITED	$19.4M	389	46	$50.0K
1	MACLEODS PHARMACEUTICALS LTD	$16.8M	336	67	$50.0K

Hetero Labs Limited ranks #2 among 104 Indian Dolutegravir exporters. Average shipment value of $50.0K compared to the market average of $1.4M. The closest competitors by value are CIPLA LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Dolutegravir Exports?

Port	Shipments	% Share
SAHAR AIR	610	18.3%
NHAVA SHEVA SEA (INNSA1)	465	14.0%
JNPT/ NHAVA SHEVA SEA	316	9.5%
SAHAR AIR CARGO ACC (INBOM4)	284	8.5%
JNPT	180	5.4%
HYDERABAD ACC (INHYD4)	164	4.9%
HYDERABAD AIR	147	4.4%
DELHI AIR	137	4.1%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Dolutegravir Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dolutegravir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 709 individual customs records matching Hetero Labs Limited exporting Dolutegravir, covering 341 formulations to 102 countries via 115 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 592+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dolutegravir

Dolutegravir

Hetero Labs Limited — Dolutegravir Exporter Profile

Hetero Labs Limited — Dolutegravir Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Dolutegravir?

Who Are the Top Buyers of Dolutegravir from Hetero Labs Limited?

What Is India's Total Dolutegravir Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Dolutegravir Exports?

How Does Hetero Labs Limited Compare to Other Indian Dolutegravir Exporters?

What Dolutegravir Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Dolutegravir to Key Markets

Nigeria — NAFDAC

South Africa — SAHPRA

How Does Hetero Labs Limited Compare to Nearest Dolutegravir Exporters?

Which Indian Ports Ship Dolutegravir Exports?

What Other Antiviral & HIV Medications Products Does Hetero Labs Limited Export?

Dolutegravir — Export Intelligence Video

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Dolutegravir Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dolutegravir Export Data from Hetero Labs Limited

Dolutegravir Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source